Author: KCCure

KCCure Awards $50,000 to Memorial Sloan Kettering Researchers for their work in Chromophobe Renal Cell Carcinoma

March 31, 2022 The Kidney Cancer Research Alliance (KCCure) announced today that Dr. Ming Li and Dr. Martin Voss with Memorial Sloan Kettering Cancer Center have been selected to receive the inaugural KCCure Chromophobe Research Grant Award of $50,000 for their proposal: Tumor-resident cytotoxic innate lymphocytes (ILC) as novel targets for immunotherapy in chromophobe renal cell carcinoma (c...

Addressing Diagnostic Uncertainty in Localized Kidney Cancer

Many patients will be told that they have localized kidney cancer based solely on imaging alone. This can give the impression that diagnostic accuracy of scans is higher than it actually is. While CT scans are predictive of renal cell carcinoma and are routinely used to recommend surgery – the only definitive way to know for sure whether a renal mass is cancer is surgical removal. As many as 20 pe...

Voice of Kidney Cancer – The Story of Benny

Sometimes Angels Don’t Have Wings – They Have Paws Eleven years ago I was diagnosed with renal cell carcinoma. If you or a loved one has been impacted by cancer, I don’t have to tell you what that day was like. Almost to the day, Benny came into my life. He was small and all he wanted to do was be with me all of the time.  Since my initial diagnosis, I have endured five surgeries,...

Rare Disease Day 2022

In the United States, a rare disease is defined as a disease that impacts fewer than 200,000 people. In the European Union, it is defined as a disease that effects 1 in 2,000.  Kidney cancer patients know they have a rare disease because they hear this: “We hardly ever see this subtype of kidney cancer…”  “There are treatments we can try, but we don’t know if they will work for you.” Mos...

Kidney Cancer Awareness – March 2022

March is Kidney Cancer Awareness Month! Over 400,000 people worldwide will be diagnosed with kidney cancer this year. In the United States, 500,000 Americans are living with kidney cancer and 70,000 more will be diagnosed. March is our month to raise awareness about the impact of this disease and the need for more research.  Over the last few months, the world has been captivated by shared pu...

KCCure Announces New Research Grant For Chromophobe Renal Cell Carcinoma

November 19, 2021 KCCure is offering a grant totaling $50,000 for a project focused on innovative scientific research in chromophobe renal cell carcinoma (RCC).  Chromophobe RCC is a rare subtype of kidney cancer accounting for roughly 5 percent of RCC tumors. When discovered early, this histological type is less likely to spread to other parts of the body. However, once the disease becomes m...

FDA approves the combination of lenvatinib (Lenvima) plus pembrolizumab (Keytruda) for first-line treatment of advanced renal cell carcinoma (RCC)

On August 10, 2021, the Food and Drug Administration approved the combination of lenvatinib (Lenvima) plus pembrolizumab (Keytruda) for first-line treatment of adult patients with advanced renal cell carcinoma (RCC). Pembrolizumab is an anti-PD-1 checkpoint inhibitor that helps the immune system detect and fight tumor cells. Lenvatinib is an anti-angiogenic targeted therapy that inhibits growth of...

No Tie July 2021

What is No Tie July? No Tie July is our annual fundraising effort where we raise $50,000 – one year of research funding – in just one month! Since our launch in 2016, this fundraising effort has helped us to award $400,000 in direct research grants. How Can You Participate? 1.) Designate a Research Priority This year, we are excited to unveil a new feature of our Research Grant Program...

Kidney Cancer Awareness – Our Voice!

This month, we have had the opportunity to share some remarkable RCC survivor stories revealing the depth and breadth of the patient experience. We are grateful to all of the patients and caregivers who participated in this effort. Your stories provide a rich and honest narrative of the patient experience, reminding us that kidney cancer is not one disease and that experiences vary for so many rea...

Voice of Kidney Cancer – Eric Smith

My kidney cancer was found shortly after I saw blood in my urine in December of 2010. Like everyone else who gets a cancer diagnosis, I experienced the sickening anxiety of being informed I had a suspicious mass.  In my case, I was told over the phone by a urology PA that the ultrasound had detected a “large mass” in my right kidney that was probably malignant. A radical nephrectomy (laparosc...

Voice of Kidney Cancer – Catherine Yutmeyer

My name is Catherine Yutmeyer. I am 39 years old and live in Central Illinois with my husband and 7 year old son. I have practiced family medicine as a PA for 14 years. I never expected to be a patient myself, and especially not to be the youngest cancer patient in my practice.  My cancer journey started in March of 2020. I felt great and had no symptoms. I was standing in front of the mirror...

Lost Password

Register

Subscribe for updates!